Vasopressor Choice and Timing in Vasodilatory Shock

Patrick M Wieruszewski; Ashish K Khanna

doi:10.1186/s13054-022-03911-7

Vasopressor Choice and Timing in Vasodilatory Shock

Crit Care. 2022 Mar 22;26(1):76. doi: 10.1186/s13054-022-03911-7.

Authors

Patrick M Wieruszewski¹, Ashish K Khanna^{2

3}

Affiliations

¹ Departments of Anesthesiology and Pharmacy, Mayo Clinic, Rochester, MN, USA.
² Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. akhanna@wakehealth.edu.
³ Outcomes Research Consortium, Cleveland, OH, USA. akhanna@wakehealth.edu.

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Critical Care
Humans
Hypotension*
Shock* / drug therapy
Vasoconstrictor Agents / pharmacology
Vasoconstrictor Agents / therapeutic use

Substances

Vasoconstrictor Agents

Grants and funding

KL2 TR001421/TR/NCATS NIH HHS/United States